Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Identix (IDNX) -- Ignore unavailable to you. Want to Upgrade?

To: steve who wrote (8370)	5/16/1998 9:50:00 PM
From: Loretta Fern	Respond to of 26039

Things certainly could be worse at IDX. The nrid 10-q (see nrid thread if interested) graphically describes a company circling the drain. THE NATIONAL REGISTRY INC. MANAGEMENT'S DISCUSSION AND ANALYSIS - (CONTINUED) While the Company has sold certain software licenses and various other products for approximately $2.9 million to XL Vision (as discussed earlier under RECENT DEVELOPMENTS - MASTER RESELLER) approximately $875,000 of the payments under that agreement are scheduled to be received during the second quarter of 1998 with the remainder scheduled to be received during the rest of 1998. The Company does not believe that the receipt of such payments will address the Company's cash flow requirements. Accordingly, the Company is reviewing the options available to it to obtain additional financing. These options include, but are not limited to, the sale and issuance of stock, the sale and issuance of debt, the sale of certain assets of the Company and entering into an additional strategic relationship or relationships to either obtain the needed funding or to create what the Company believes would be a better opportunity to obtain such funds. It is very possible that any such additional infusion of capital would be in the form of the sale and issuance of additional shares of Common Stock or securities that are convertible into Common Stock, which would substantially increase the number of shares of Common Stock outstanding on a fully-diluted basis. However, there is a significant likelihood that additional funding or strategic relationships will not be available on terms acceptable to the Company, if at all. The failure to obtain such additional funds would cause the Company to cease or curtail operations. Even if such additional funding is obtained, there is no assurance that the Company will be able to generate significant sales of its products or services, or, if the Company is able to consummate significant sales, that any such sales would be profitable. I guess my last two posts on sacm and nrid are meant to show the difficulty of prospering in today's biometrics environment. Randy and IDX are in comparison, doing quite well. BTW- sacm market cap is 50 million dollars. Do some price to sales comparisons to make IDX look real cheap.

To: steve who wrote (8370)	5/16/1998 9:55:00 PM
From: David	Read Replies (1) \| Respond to of 26039

Looks like NRID lost that lawsuit . . . from its SEC filing: "SETTLEMENT OF LAWSUIT - On May 15, 1998, the Company reached a settlement of a lawsuit filed by IIG on February 13, 1997. IIG asserted multiple claims which include breach of contract, quantum meruit, unjust enrichment, breach of the implied covenant of good faith and fair dealing and fraud and seeks an accounting, specific performance, injunctive and declaratory relief and damages. The settlement includes a $300,000 cash payment made by the Company on May 15, 1998, the issuance to IIG of 250,000 shares of Common Stock, and the granting to IIG of an option to purchase 450,000 shares of Common Stock at an exercise price of $0.5625, the closing bid price of the Common Stock on the SmallCap Market on April 3, 1998 (the day the preliminary settlement was reached). Under the terms of the settlement the lawsuit will be dismissed with prejudice."